Search

everythinglearnresearchcommunity

for

Search:↓

Different hair loss patterns may be linked to varying male hormone levels.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

AMH is a reliable marker for diagnosing PCOS.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Adult female acne is complex and requires a combination of treatments for effective management.

More body hair in young Australian women is linked to higher androstenedione levels.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Oral lichen planus is not linked to sex hormone levels.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Postpartum care should address hormonal changes, nutrition, and support to ensure mother and baby well-being.

Hormone replacement therapy can improve menopausal skin quality, but it's not recommended just for skin due to limited evidence.

Testosterone treatment may affect heart response to stress in transgender men.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Progesterone may help trans women with breast development and health, but more research is needed.